Health

AI ยท 251 companies ยท 438 deals tracked
251 Companies
438 Deals Tracked
AI Sector

Health Companies

Iambic Iambic ๐Ÿ‡บ๐Ÿ‡ธ TandemAI TandemAI ๐Ÿ‡บ๐Ÿ‡ธ University Of Cincinnatiโ€™s Venture Lab University Of Cincinnatiโ€™s Venture Lab ๐Ÿ‡บ๐Ÿ‡ธ mytomorrows mytomorrows ๐Ÿ‡ณ๐Ÿ‡ฑ Enodia Therapeutics Enodia Therapeutics ๐Ÿ‡ซ๐Ÿ‡ท Linda AI Linda AI ๐Ÿ‡ฎ๐Ÿ‡ช Midi Health Midi Health ๐Ÿ‡บ๐Ÿ‡ธ Medimaps Group S.a. Medimaps Group S.a. ๐ŸŒ Alaffia Health Alaffia Health ๐Ÿ‡บ๐Ÿ‡ธ Artios Artios ๐Ÿ‡ฌ๐Ÿ‡ง

Latest Deals in Health

$40M
Anterior, a clinician-led AI platform for health plans, raised $40 million in funding, totaling $64 million. The round saw participation from NEA, Sequoia Capital, FPV, and Kinnevik. Anterior addresses the challenge of AI implementation in healthcare by integrating AI into clinical workflows with clinician support, achieving 99.24% clinical accuracy. The new capital will enhance production deployments and expand use cases, demonstrating significant operational gains for health plans covering 50 million lives.
Investors: NEA, Sequoia Capital, FPV, Kinnevik
Health Feb 12, 2026
$40M
Anterior, a clinician-led AI platform for health plans, raised $40 million, totaling $64 million in funding. The investment, led by NEA and Sequoia Capital with new backers FPV and Kinnevik, aims to enhance deployment speed and integrate technology into healthcare workflows. Anterior addresses the inefficiencies in prior authorization processes, significantly reducing administrative burdens for clinicians. The platform has achieved 99.24% clinical accuracy and supports organizations covering 50 million lives.
Investors: NEA, Sequoia Capital, FPV, Kinnevik
Health Feb 12, 2026
$75M
Stockholm-based Lassie, a preventive pet insurer, has raised $75 million in Series C funding to expand across Europeโ€™s pet care and insurance market. The funding round included investors such as Balderton Capital and Felix Capital, supporting Lassie's automated and preventive care approach. Founded in 2020, Lassie integrates insurance with wellness support, addressing rising veterinary costs and enhancing customer experience through AI-driven processes.
Investors: Balderton Capital, Felix Capital
Health Feb 12, 2026
$75M
Stockholm-based Lassie, a prevention-focused pet insurer, has raised $75 million in Series C funding to expand across Europeโ€™s pet care and insurance market. The round included investors such as Balderton Capital and Felix Capital, supporting Lassie's automated and preventive care insurance model. With rising veterinary costs, Lassie's approach aims to alleviate financial pressure on pet owners. The company plans to enhance AI-supported claims processing and develop partnerships to connect routine pet care with insurance services.
Investors: Balderton Capital, Felix Capital
Health Feb 12, 2026
$75M
Lassie, based in Stockholm, raised $75 million in a Series C funding round, bringing its total funding to $120 million. The company addresses the limited and reactive pet insurance options by offering a preventive approach through a digital platform that combines insurance, daily care tools, and AI. With over 250,000 pets covered and generating about $100 million in annual recurring revenue, Lassie aims to expand into new European markets and enhance its AI capabilities.
Health Feb 12, 2026
$9.72M
Berlin-based Circle Health has secured โ‚ฌ9 million in a seed round led by Atlantic.vc, with participation from CRB Health Tech, Calm/Storm Ventures, and Kfund. The funding aims to address the fragmented European preventive healthcare market by developing Circle OS, an integrated platform that combines diagnostics, AI support, and digital health tools. Since its launch in 2023, Circle Health has treated thousands of patients in its Berlin clinic, focusing on proactive health management and planning to expand its hybrid clinic model across Germany.
Investors: Atlantic.vc, CRB Health Tech, Calm/Storm Ventures, Kfund
Health Feb 11, 2026
$23.22M
Dawn Health has raised โ‚ฌ21.5 million in a growth investment round to enhance its AI-enabled patient companion platform for pharmaceutical companies. The funding, led by Cipio Partners alongside existing investors, aims to improve disease management and clinical research while accelerating product development. CEO Alexander Mandix Hansen expressed excitement about the alignment with Cipio's capabilities and the company's vision.
Investors: Cipio Partners
Health Feb 11, 2026
$100M
Paris-based DentalMonitoring has raised $100 million in funding to expand its AI-based remote monitoring platform for orthodontics. The investment, led by Lazard Elaia Capital, aims to enhance efficiency in dental care by allowing patients to scan their teeth via smartphone while clinicians monitor progress through AI analysis. The company serves over 2 million patients globally and plans to strengthen its presence in Europe, the U.S., Australia, and Japan, while exploring new markets and product development.
Investors: Lazard Elaia Capital
Health Feb 11, 2026
$3.75M
London-based drug safety startup Sable Bio has secured $3.75 million in seed funding led by MMC Ventures, with support from Episode 1 Ventures and Seedcamp. The funding aims to enhance its platform that helps pharmaceutical companies detect safety risks earlier in drug development, addressing the costly issue of unexpected toxicity in clinical trials. Sable has generated $0.5 million in revenue and signed agreements with top pharma firms, showcasing the demand for its innovative safety assessment solutions.
Investors: MMC Ventures, Episode 1 Ventures, Seedcamp
Health Feb 11, 2026
$90.72M
French healthtech startup DentalMonitoring has raised โ‚ฌ84 million ($100 million) to enhance international expansion and product innovation. The funding, led by new investors including Lazard Elaia Capital, aims to strengthen its presence in key markets and support the development of AI-powered remote orthodontic monitoring solutions. Founded in 2014, DentalMonitoring serves over 2 million patients and plans to leverage its technology for broader dental applications.
Investors: Lazard Elaia Capital
Health Feb 11, 2026
$118M
Garner Health, a digital platform improving healthcare provider selection, has raised $118 million in Series D funding, bringing its total to approximately $200 million. Led by Kleiner Perkins with participation from several investors, the funding aims to enhance Garner's doctor ranking platform and AI-driven services. Garner addresses the U.S. healthcare system's transparency issues, helping patients access high-quality doctors while reducing costs for employers. Currently serving 2.5 million people, Garner's approach has shown to significantly lower out-of-pocket expenses for employees and healthcare spending for employers.
Investors: Kleiner Perkins
Health Feb 10, 2026
$4M
Behuman, a physician-led preventive-care platform, has secured a $4 million seed round to enhance cancer detection in underserved populations. The funding was led by Santรฉ Ventures, with participation from Digital Health Venture Partners. Founded by Steve Yaskin, Behuman aims to address late cancer detection by providing accessible screenings through advanced diagnostics and AI-driven care coordination. The company reports that its cancer detection rates exceed national averages and plans to expand its services into additional states and deepen partnerships with diagnostic laboratories.
Investors: Santรฉ Ventures, Digital Health Venture Partners
Health Feb 10, 2026
$4M
Behuman, a physician-led preventive-care platform, has secured a $4 million seed round to improve cancer detection in underserved populations. The funding was led by Santรฉ Ventures, with participation from Digital Health Venture Partners. Founded by Steve Yaskin, Behuman aims to reach insured patients who often miss screenings due to barriers like geography and access. The company utilizes advanced diagnostics and AI-driven care coordination to enhance early detection rates, which reportedly exceed national averages. The new funding will support expansion into more states and strengthen partnerships with diagnostic labs.
Investors: Sante Ventures, Digital Health Venture Partners
Health Feb 10, 2026
$4M
Behuman, a physician-led preventive-care platform, has secured a $4 million seed round to enhance cancer detection in underserved populations. The funding, led by Santรฉ Ventures with participation from Digital Health Venture Partners, aims to address late cancer detection among insured Americans who lack access to screenings. Behuman utilizes advanced diagnostics and AI-driven care coordination to improve early detection rates, which reportedly exceed national averages. The new capital will facilitate expansion into additional states and strengthen partnerships with diagnostic labs.
Investors: Santรฉ Ventures, Digital Health Venture Partners
Health Feb 10, 2026
$10M
Microsynetics, a Soest, Germany-based startup, raised $10 million in Series A funding for its AI-powered senior safety solution called Gardia. The funding round was led by Peak, with participation from Amberra and Butterfly & Elephant, along with existing backers. The company plans to use the funds to expand across the DACH region and grow its B2B partnerships.
Investors: Peak, Amberra, Butterfly & Elephant
Health Feb 9, 2026
$29M
Galux, a biotech company based in Seoul, South Korea, raised $29 million in Series B funding to develop AI-driven protein therapeutics. The funding round was led by Intervest and Dayli Partners, with participation from existing investors and new investors including Yuanta Investment and Korea Development Bank.
Investors: Intervest, Dayli Partners, Yuanta Investment, Korea Development Bank
Health Feb 9, 2026
$29M
Galux, a South Korea-based biotech company specializing in AI-driven protein therapeutics design, has secured $29 million in Series B financing, increasing its total capital raised to $47 million. This funding aims to enhance drug discovery processes through innovative protein design solutions.
Health Feb 9, 2026
$1.08M
Runeasi, a Leuven-based company specializing in AI-driven running and gait analysis, has secured โ‚ฌ1 million in funding. The investment, led by Smarter Ventures with participation from Freshmen Fund, Gemma Frisius Fund, and angel investor Sean Gourley, aims to accelerate international expansion and enhance its motion analysis technology. The platform is currently utilized in over 40 countries, having completed more than 50,000 analyses, and focuses on providing accurate data for sports physiotherapists and coaches.
Investors: Smarter Ventures, Freshmen Fund, Gemma Frisius Fund, Sean Gourley
Health Feb 9, 2026
$1.08M
Runeasi, a Leuven, Belgium-based provider of an AI platform for running and gait analysis, raised โ‚ฌ1 million in funding. The round was led by Smarter Ventures, with participation from existing investors Freshmen Fund, Gemma Frisius Fund, the company's founders, and angel investor Sean Gourley. The funds will be used to accelerate international expansion.
Investors: Smarter Ventures, Freshmen Fund, Gemma Frisius Fund, Sean Gourley
Health Feb 9, 2026
$100M
Midi Health raised $100 million in a Series D financing round, achieving a valuation of over $1 billion. The funding will help the women's telehealth company expand its AI-enabled platform beyond perimenopause and menopause care to address women's health across various life stages.
Health Feb 7, 2026